Available to sourceHuman Prescription DrugOncology & Specialty

POTELIGEO (mogamulizumab-kpkc)

4 mg/mL · Injection

By Kyowa Kirin, Inc.

NDC: 42747-761
Route: Intravenous
Therapeutic class: Antibodies, Monoclonal [CS], Chemokine Receptor Type 4 Interaction , Chemokine Receptor Type 4 Interactions [MoA], Monoclonal Antibody
Marketing category: BLA

Package sizes

1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASSNDC 42747-761-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Oncology & Specialty

See all →

POTELIGEO (mogamulizumab-kpkc)

Package sizes

Additional information

Request this medication

Related in Oncology & Specialty

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)